3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
32
Breast Neoplasms
25
Fallopian Tube Neoplasms
21
Multiple Myeloma
18
Carcinoma, Ovarian Epithelial
14
Lymphoma
8
Triple Negative Breast Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hodgkin Disease
3
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Hematologic Neoplasms
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Patient Participation
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Interventions
Paclitaxel
5
Carboplatin
3
Taxes
2
Specimen Handling
2
Nivolumab
2
Biopsy
2
rucaparib
1
rebastinib
1
pembrolizumab
1
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
cabozantinib
1
Magnetic Resonance Spectroscopy
1
LY-2157299
1
Immunoglobulin G
1
Ifosfamide
1
Fluid Therapy
1
Disulfides
1
DCC-2036
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinosarcoma
×
liposomal doxorubicin
×
Clear all
No trials found.